Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design
- PMID: 8807211
- PMCID: PMC170365
- DOI: 10.1128/cdli.3.4.444-450.1996
Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design
Abstract
The currently used serological subtyping scheme for the pathogen Neisseria meningitidis is not comprehensive, a proportion of isolates are reported as not subtypeable (NST), and few isolates are fully characterized with two subtypes for each strain. To establish the reasons for this and to assess the effectiveness of DNA-based subtyping schemes, dot blot hybridization and nucleotide sequence analyses were used to characterize the genes encoding antigenic variants of the meningococcal subtyping antigen, the PorA protein. A total of 233 strains, including 174 serologically NST and 59 partially or completely subtyped meningococcal strains, were surveyed. The NST isolates were chosen to be temporally and geographically representative of NST strains, isolated in England and Wales, and submitted to the Meningococcal Reference Unit in the period 1989 to 1991. The DNA-based analyses demonstrated that all of the strains examined possessed a porA gene. Some of these strains were serologically NST because of a lack of monoclonal antibodies against certain PorA epitopes; in other cases, strains expressed minor variants of known PorA epitopes that did not react with monoclonal antibodies in serological assays. Lack of expression remained a possible explanation for serological typing failure in some cases. These findings have important implications for epidemiological analysis and vaccine design and demonstrate the need for genetic characterization, rather than phenotypic characterization using monoclonal antibodies, for the identification of meningococcal strains.
Similar articles
-
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.J Clin Microbiol. 2000 Sep;38(9):3323-8. doi: 10.1128/JCM.38.9.3323-3328.2000. J Clin Microbiol. 2000. PMID: 10970378 Free PMC article.
-
Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.Microbiology (Reading). 1996 Jan;142 ( Pt 1):63-69. doi: 10.1099/13500872-142-1-63. Microbiology (Reading). 1996. PMID: 8581171
-
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.Infect Immun. 1996 Jul;64(7):2745-51. doi: 10.1128/iai.64.7.2745-2751.1996. Infect Immun. 1996. PMID: 8698504 Free PMC article. Clinical Trial.
-
Expression of meningococcal epitopes in LamB of Escherichia coli and the stimulation of serosubtype-specific antibody responses.Mol Microbiol. 1993 Oct;10(1):203-13. doi: 10.1111/j.1365-2958.1993.tb00916.x. Mol Microbiol. 1993. PMID: 7526119
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
Cited by
-
Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.Clin Diagn Lab Immunol. 1998 Nov;5(6):845-55. doi: 10.1128/CDLI.5.6.845-855.1998. Clin Diagn Lab Immunol. 1998. PMID: 9801347 Free PMC article.
-
Carriage rates and serogroups of Neisseria meningitidis among freshmen in a University dormitory in Korea.Yonsei Med J. 2012 Jul 1;53(4):742-7. doi: 10.3349/ymj.2012.53.4.742. Yonsei Med J. 2012. PMID: 22665340 Free PMC article.
-
Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.J Clin Microbiol. 2001 Apr;39(4):1235-40. doi: 10.1128/JCM.39.4.1235-1240.2001. J Clin Microbiol. 2001. PMID: 11283034 Free PMC article.
-
Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis.J Clin Microbiol. 2001 Sep;39(9):3066-71. doi: 10.1128/JCM.39.9.3066-3071.2001. J Clin Microbiol. 2001. PMID: 11526130 Free PMC article.
-
Redesignation of a purported P1.15 subtype-specific meningococcal monoclonal antibody as a P1.19-specific reagent.Clin Diagn Lab Immunol. 1999 Jul;6(4):639-42. doi: 10.1128/CDLI.6.4.639-642.1999. Clin Diagn Lab Immunol. 1999. PMID: 10391880 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical